Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Thrombosis 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Multiple Myeloma 2 Disease 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombophilia 1 Thrombocytopenia 1 Thoracic Neoplasms 1 Skin Neoplasms 1 Pituitary Neoplasms 1 Pediatric Solid Tumor, Unspecified, Protocol Specific 1 Papillomavirus Infections 1

Interventions

Radiotherapy 8 Zoledronic Acid 7 Fentanyl 7 nabiximols 6 Morphine 6 Ibandronic Acid 6 Ketamine 5 Hydromorphone 5 Analgesia 5 Acetaminophen 5 Tapentadol 4 Oxycodone 4 Acupuncture Therapy 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Duloxetine Hydrochloride 2 Docetaxel 2 Calcium 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 strontium chloride 1 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Injections × Clear all

NCT01836328 2016-03-16

RATIOMTD

L'Hospitalet de Llobregat

Phase 3 Completed

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡